Shionogi & Co., Ltd. (TYO:4507)

Market Cap	2.45T +15.4%
Revenue (ttm)	499.68B +14.0%
Net Income	205.16B +20.4%
EPS	241.04 +20.3%
Shares Out	850.98M
PE Ratio	11.93
Forward PE	11.50
Dividend	76.00 (2.64%)
Ex-Dividend Date	Mar 30, 2026

Volume	3,007,500
Open	2,918.50
Previous Close	2,876.00
Day's Range	2,869.50 - 2,925.50
52-Week Range	2,392.50 - 3,758.00
Beta	0.04
Analysts	Buy
Price Target	3,404.17 (+17.39%)
Earnings Date	Aug 3, 2026

About Shionogi &

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. It is also involved in consumer healthcare business; manufacturing, sale, analytical testing, and pharmaceutical engineering of medicinal drugs and investigational drugs; contracted monitoring of epidemiological components in sewage; promotion of implementation in social infrastructure; and business related to providing data and information; develops and sells foothol...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1878
• Employees: 6,223
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4507

Financial Performance

In fiscal year 2026, Shionogi &'s revenue was 499.68 billion, an increase of 14.01% compared to the previous year's 438.27 billion. Earnings were 205.16 billion, an increase of 20.37%.

Analyst Summary

According to 12 analysts, the average rating for 4507 stock is "Buy." The 12-month stock price target is ¥3,404, which is an increase of 17.39% from the latest price.

Price Target

¥3,404

(17.39% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 21, 2026

Data Sources Report a data error